Dassault Systemes Shares Jump After Revenue Growth Beat Forecasts
By Mauro Orru
Shares of Dassault Systemes climbed Wednesday after the French software maker posted revenue and operating profit ahead of analysts' expectations for the third quarter.
At 0900 GMT, Dassault Systemes shares traded 6.1% higher at EUR37.13.
Reporting on a non-IFRS basis, the group said overall revenue grew 11% on year at constant currencies to 1.42 billion euros ($1.50 billion), with software revenue up 12% to EUR1.29 billion and services revenue up 2% to EUR138 million.
Operating profit increased to EUR442 million from EUR433.5 million, generating a 31% operating margin.
Dassault's results beat consensus of EUR1.41 billion on revenue, EUR430.5 million on operating profit and 30.4% on operating margin, Jefferies analysts wrote in a note to clients.
Dassault Systemes had projected third-quarter revenue of EUR1.40 billion to EUR1.42 billion, and an operating margin of 30.2% to 30.5%.
For the fourth quarter, it expects revenue between EUR1.64 billion and EUR1.68 billion, with an operating margin of 35.8% to 36.6%.
For the year, revenue should come in between EUR5.95 billion and EUR5.99 billion, with an operating margin of 32.3% to 32.6%.
Dassault Systemes, like other European software companies, presents its figures as two sets of numbers. One set is based on the International Financial Reporting Standards--an international accounting method that seeks to provide a global reporting standard--though analysts and investors tend to follow non-IFRS numbers. Those figures exclude share-based compensation, restructuring expenses and acquisition-related charges.
Write to Mauro Orru at mauro.orru@wsj.com
(END) Dow Jones Newswires
October 25, 2023 05:18 ET (09:18 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth